Pharsight

Arbor Pharms Llc patents expiration

1. Cetylev patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8747894 ARBOR PHARMS LLC Effervescent compositions containing N-acetylcysteine
May, 2032

(7 years from now)

US9561204 ARBOR PHARMS LLC Effervescent compositions containing N-acetylcysteine
May, 2032

(7 years from now)

US9427421 ARBOR PHARMS LLC Effervescent compositions containing N-acetylcysteine
May, 2032

(7 years from now)

Drugs and Companies using ACETYLCYSTEINE ingredient

Market Authorisation Date: 29 January, 2016

Treatment: Method of treating acetaminophen overdose with acetylcysteine solutions

Dosage: TABLET, EFFERVESCENT;ORAL

More Information on Dosage

CETYLEV family patents

Family Patents

2. Sklice patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6103248 ARBOR PHARMS LLC Topical preparation and therapy for head lice
May, 2018

(6 years ago)

US8791153 ARBOR PHARMS LLC Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice
Oct, 2027

(3 years from now)

US8927595 ARBOR PHARMS LLC Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice
Oct, 2027

(3 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Feb 07, 2015

Drugs and Companies using IVERMECTIN ingredient

Market Authorisation Date: 07 February, 2012

Treatment: For head lice infestations

Dosage: LOTION;TOPICAL

How can I launch a generic of SKLICE before it's drug patent expiration?
More Information on Dosage

SKLICE family patents

Family Patents